Find a Commonwealth Resource
Rufinamide
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Rufinamide is an oral suspension medication containing 40 mg/mL of rufinamide, used to treat seizures associated with Lennox-Gastaut syndrome. Manufactured by Aurobindo Pharma Limited under ANDA216549, it's available as a prescription drug in 460 mL bottles. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Rufinamide
Access the FDA dataset for Rufinamide — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025